483
CSL Plasma IncCSL Plasma Inc – FDA 483, Mar 22, 2023
Record Details
An FDA inspection of CSL Plasma, Inc. in Las Vegas, Nevada, revealed a critical deficiency in donor notification procedures. The firm failed to inform donors of reactive test results for relevant transfusion-transmitted infections, including positive HIV screening and confirmatory results, which led to donor deferral. This indicates a serious non-compliance with established protocols for unsuitable events management.
- Person
View Company Profile
ID · d0d28a4d-c691-4a20-8cfb-65734e1cfe1c
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.